€ €
J. Hausler and H. Kahlig
724
The benzoylation of 9a, 9b was carried out in 30cm3 of ice cold CHCl3 with the four times molar
amount of benzoyl chloride and pyridine, and catalysis with 4-(dimethylamino)pyridine (5mol%).
After 10h at room temp. the solvent was removed in vacuo. The residue was taken up in 80cm3 of
ethyl acetate, and the solution was extracted subsequently with H2O, 1 M HCl, and finally with satd.
aqueous NaHCO3. The organic layer was dried (Na2SO4) and the solvent evaporated in vacuo. Thin
layer analysis (silica, CHCl3:MeOH¼ 95:5) of the crude oil (3.8g) indicated 10a (Rf ¼ 0.46), 10b
(Rf ¼ 0.30), and components at the start and the front. Chromatography of the oil on a Chromatotron
(CHCl3:MeOH ¼ 99:1) afforded 10a and 10b (1.3 g each, 90%).
(3R,5R)-3,5-Dibenzoyloxy-2-piperidone (10a, C19H17NO5)
20
Colourless needles, mp 147–149ꢄC (CHCl3:ether¼ 1:9); ½ꢁꢅD ¼ 172.5ꢄ cm2 gꢆ1 (c ¼ 1.53, CHCl3);
1H NMR (CDCl3): ꢀ ¼ 2.44 (ddd, J ¼ 2.9, 11.4, 13.7 Hz, C–CHH–C), 2.70 (dddd, J ¼ 2.0, 4.5, 6.4,
13.7Hz, C–CHH–C), 3.62 (dddd, J ¼ 2.0, 2.9, 2.9, 13.6Hz, N–CHH), 3.80 (ddd, J ¼ 1.4, 3.8, 13.6Hz,
N–CHH), 5.60 (ddddd, J ¼ 0.8, 2.9, 2.9, 3.8, 4.5 Hz, O–CH), 5.79 (dd, J ¼ 6.4, 11.4Hz, O–CH), 6.15
(bs, NH), 7.35–7.48 (m, 4HAr), 7.51–7.63 (m, 2HAr), 7.99–8.11 (m, 4HAr) ppm; 13C NMR (CDCl3):
ꢀ ¼ 31.58 (CH2), 46.20 (N–CH2), 66.34 (O–CH), 66.39 (O–CH), 128.38, 128.58, 129.77, 129.97,
133.34, 133.60 (Ar), 129.30, 129.49 (Arqu), 165.62, 165.70, 168.40 (CO) ppm.
(3S,5R)-3,5-Dibenzoyloxy-2-piperidone (10b, C19H17NO5)
20
Colourless fluffy needles, mp 114–116ꢄC (CHCl3:ether¼ 1:9); ½ꢁꢅD ¼ 59.2ꢄ cm2 gꢆ1 (c ¼ 1.03, CHCl3);
1H NMR (CDCl3): ꢀ ¼ 2.46 (dddd, J ¼ 0.9, 6.7, 8.0, 14.2Hz, C–CHH–C), 2.74 (dddd, J ¼ 0.5, 4.9, 7.1,
14.2Hz, C–CHH–C), 3.63 (dddd, J ¼ 0.9, 3.8, 4.9, 13.1Hz, N–CHH), 3.71 (dddd, J ¼ 0.5, 2.4, 4.0,
13.1Hz, N–CHH), 5.46 (ddddd, J ¼ 0.5, 4.0, 4.9, 4,9, 6.7 Hz, O–CH), 5.62 (dd, J ¼ 7.1, 8.0 Hz, O–CH),
6.21 (bs, NH), 7.30–7.44 (m, 4HAr), 7.47–7.59 (m, 2HAr), 7.97–8.04 (m, 4HAr) ppm; 13C NMR
(CDCl3): ꢀ ¼ 32.59 (CH2), 45.49 (N–CH2), 65.48 (O–CH), 66.29 (O–CH), 128.27, 128.45, 129.77,
129.94, 133.24, 133.43 (Ar), 129.34, 129.41 (Arqu), 165.54, 165.61, 168.40 (CO) ppm.
(3R,5R)- and (3S,5R)-3,5-Dihydroxy-2-piperidones 9a and 9b
Under Ar three small drops of a 1 M solution of NaOCH3 in CH3OH were added to solutions of
1.5 mmol of 10a or 10b in 50cm3 of dry CH3OH. After 48–60h the starting materials and the
intermediate mono benzoates could not longer be detected by thin layer chromatography (silica 60,
CHCl3:MeOH ¼ 9:1). Acetic acid (1 drop) was added, the solvent was evaporated in vacuo, and the
residue was filtered through a short column of silica (eluent: CHCl3:MeOH ¼ 7:3) and crystallized
from CH3OH–ether.
(3R,5R)-3,5-Dihydroxy-2-piperidone (9a, C5H9NO3)
20
1
Yield 83%; colourless needles, mp 131–133ꢄC; ½ꢁꢅD ¼ 61.8ꢄ cm2 gꢆ1 (c ¼ 1.2, MeOH); H NMR:
ꢀ ¼ 2.13 (ddd, J ¼ 2.9, 10.8, 13.6Hz, C–CHH–C), 2.49 (dddd, J ¼ 1.8, 5.1, 6.3, 13.6Hz, C–CHH–C),
3.41 (ddd, J ¼ 1.8, 3.4, 13.5Hz, N–CHH), 3.70 (dd, J ¼ 3.8, 13.5Hz, N–CHH), 4.48 (dddd, J ¼ 2.9,
3.4, 3.8, 5.1 Hz, O–CH), 4.53 (dd, J ¼ 6.3, 10.8Hz, O–CH) ppm; 13C NMR: ꢀ ¼ 35.91 (CH2), 48.39
(N–CH2), 63.63 (O–CH), 64.69 (O–CH), 175.18 (CO) ppm.
(3S,5R)-3,5-Dihydroxy-2-piperidone (9b, C5H9NO3)
20
Yield 79%; colourless crystals, mp 138ꢄC; ½ꢁꢅD ¼ 17.3ꢄ cm2 gꢆ1 (c ¼ 1.1, MeOH); 1H NMR: ꢀ ¼ 1.94
(ddd, J ¼ 8.8, 10.5, 12.7Hz, C–CHH–C), 2.68 (dddd, J ¼ 1.3, 4.8, 6.8, 12.7Hz, C–CHH–C), 3.34